4-Chloro-3-(Trifluoromethyl)phenyl Isocyanate CAS 327-78-6 Maʻemaʻe ≥99.0% Sorafenib Tosylate Intermediate Factory
Hāʻawi Kūʻai ʻo Sorafenib Tosylate a me nā mea waena e pili ana:
Sorafenib Tosylate CAS: 475207-59-1
Sorafenib CAS: 284461-73-0
4-Chloro-N-Methyl-2-Pyridinecarboxamide CAS: 220000-87-3
4-(4-Aminophenoxy)-N-Methylpicolinamide CAS: 284462-37-9
4-Chloro-3-(Trifluoromethyl)phenyl Isocyanate CAS: 327-78-6
Inoa | 4-Chloro-3-(Trifluoromethyl) phenyl Isocyanate |
Nā huaʻōlelo like | Isocyanic Acid 4-Chloro-3-(Trifluoromethyl)phenyl Ester |
Helu CAS | 327-78-6 |
Helu CAT | RF-PI167 |
Kūlana Kūʻai | Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā tona |
ʻĀpana Molekala | C8H3ClF3NO |
Kaumaha Molecular | 221.56 |
Lae hehee | 37.0~42.0℃ (māmā) |
Lae paila | 86.0~90.0℃ 14 mmHg (māmā) |
ʻO ka mānoanoa | 1.4720 |
Nā Kūlana Hoʻouna | Ambient |
Brand | ʻO Ruifu Chemical |
'ikamu | Nā kikoʻī |
Ka nana aku | Keokeo Crystalline |
Maʻemaʻe / Kaʻina Hanana | ≥99.0% (HPLC) |
ʻIkepili | (1) IR (2) HPLC |
Māmā (KF) | ≤0.50% |
Metala Kaumaha | ≤10ppm |
haumia A | ≤0.15% |
haumia B | ≤1.0% |
haumia C | ≤1.0% |
ʻO nā mea haumia hoʻokahi | ≤0.50% |
Huina paumaele | ≤1.0% |
Koena Solvent | Toluene ≤0.089% |
Kūlana hoʻāʻo | ʻOihana Kūlana |
Hoʻohana | Ka waena o Sorafenib Tosylate (CAS: 475207-59-1) |
Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, pahu pahu pahu, 25kg / pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Palekana mai ka malamalama, ka ma'ū a me ka pest infestation.
Mea Hana me ka Maʻemaʻe kiʻekiʻe a me ka maikaʻi paʻa
Hāʻawi Kalepa Sorafenib Tosylate (CAS: 475207-59-1) Nā Kūwaena Pili:
Sorafenib Tosylate CAS: 475207-59-1
Sorafenib CAS: 284461-73-0
4-Chloro-N-Methyl-2-Pyridinecarboxamide CAS: 220000-87-3
4-(4-Aminophenoxy)-N-Methylpicolinamide CAS: 284462-37-9
4-Chloro-3-(Trifluoromethyl)phenyl Isocyanate CAS: 327-78-6
ʻO Sorafenib Tosylate (CAS: 475207-59-1) kahi ʻano hou o ka lāʻau antitumor multi-target, i hoʻomohala ʻia e ka German Bayer Pharmaceuticals, a hōʻike i ka hana antitumor expansive i nā hoʻokolohua holoholona preclinical.Loaʻa ka Sorafenib i nā papa 200-mg no ka hoʻokele waha a hoʻohana ʻia i ka mālama ʻana o RCC a me HCC.Hiki i ka Sorafenib Tosylate (CAS: 475207-59-1) i ka manawa like ke hoʻopā i nā pūnaewele tumo a me nā kīʻaha koko koko.Loaʻa iā ia ka hopena antitumor pālua: hiki iā ia ke ālai i nā ala transduction hōʻailona cell i hoʻopili ʻia e RAF/MEK/ERK e hoʻopaʻa pololei i ka ulu ʻana o ka cell tumor, ʻoiai ke kāohi pū nei i ka VEGF a me nā platelet derived growth factor (PDGF) i mea e pale ai i ke kūkulu ʻana i ke koko koko hou. nā moku, no laila ke keʻakeʻa nei i ka ulu ʻana o nā cell tumor.